» Articles » PMID: 38826239

Absence of C-Maf and IL-10 Enables Type I IFN Enhancement of Innate Responses to Low-dose LPS in Alveolar Macrophages

Overview
Journal bioRxiv
Date 2024 Jun 3
PMID 38826239
Authors
Affiliations
Soon will be listed here.
Abstract

Alveolar macrophages (AMs) are lower-airway resident myeloid cells and are among the first to respond to inhaled pathogens. Here, we interrogate AM innate sensing to Pathogen Associated Molecular Patterns (PAMPs) and determine AMs have decreased responses to low-dose LPS compared to other macrophages, as measured by TNF, IL-6, , and . We find the reduced response to low-dose LPS correlates with minimal TLR4 and CD14 surface expression, despite sufficient internal expression of TLR4. Additionally, we find that AMs do not produce IL-10 in response to a variety of PAMPs due to low expression of transcription factor c-Maf and that lack of IL-10 production contributes to an enhancement of pro-inflammatory responses by Type I IFN. Our findings demonstrate that AMs have cell-intrinsic dampened responses to LPS, which is enhanced by type I IFN exposure. These data implicate conditions where AMs may have reduced or enhanced sentinel responses to bacterial infections.

References
1.
Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J . Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood. 2006; 109(4):1574-83. DOI: 10.1182/blood-2006-06-032961. View

2.
Mishra R, Potteti H, Tamatam C, Elangovan I, Reddy S . c-Jun Is Required for Nuclear Factor-κB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages. Am J Respir Cell Mol Biol. 2016; 55(5):667-674. PMC: 5105182. DOI: 10.1165/rcmb.2016-0028OC. View

3.
Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J . Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022; 606(7914):585-593. PMC: 9288243. DOI: 10.1038/s41586-022-04802-1. View

4.
Svedberg F, Brown S, Krauss M, Campbell L, Sharpe C, Clausen M . The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation. Nat Immunol. 2019; 20(5):571-580. PMC: 8381729. DOI: 10.1038/s41590-019-0352-y. View

5.
Salez L, Singer M, Balloy V, Creminon C, Chignard M . Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure. Comparison with peritoneal macrophages. J Leukoc Biol. 2000; 67(4):545-52. DOI: 10.1002/jlb.67.4.545. View